Free GLP-1 tool
GLP-1 Missed Dose & Next Injection Planner
See what the current prescribing information says after a missed weekly injection — not a new dose plan.
What this result means
Apply the official missed-dose instruction for a supported medication and presentation.
Date math uses the encoded official window for the selected presentation. If the next Wegovy dose is more than 48 hours away, the label says to take the missed dose; if it is less than 48 hours away, the label says to skip. An entry that lands exactly at 48 hours fails closed because the label does not classify that boundary. Two or more consecutive Wegovy injection misses fail closed to the clinician: the current prescribing information calls for reinitiating dosage escalation at a lower dosage, and this tool does not determine the restart dose.
What this tool cannot tell you
- Whether to double, split, or make up a dose.
- What restart dose to use after a long interruption.
- Whether you should escalate after a missed dose.
Methodology & sources
Date math uses the encoded official window for the selected presentation. If the next Wegovy dose is more than 48 hours away, the label says to take the missed dose; if it is less than 48 hours away, the label says to skip. An entry that lands exactly at 48 hours fails closed because the label does not classify that boundary. Two or more consecutive Wegovy injection misses fail closed to the clinician: the current prescribing information calls for reinitiating dosage escalation at a lower dosage, and this tool does not determine the restart dose.
- WEGOVY (semaglutide) injection / tablet prescribing information
U.S. National Library of Medicine DailyMed / Novo Nordisk · 2026-06 · Last verified 2026-09-16
Used for Wegovy injection missed-dose, labeled weekly schedule, presentation-specific storage, and labeled injection pharmacokinetics (approximately 1-week half-life; present about 5 to 7 weeks after the last 2.4 mg or 7.2 mg injection). Tablet rules are not encoded.
- OZEMPIC (semaglutide) injection prescribing information
U.S. National Library of Medicine DailyMed / Novo Nordisk · Last verified 2026-09-16
Used for Ozempic missed-dose, labeled weekly schedule, pen/syringe storage, and labeled injection pharmacokinetics (approximately 1-week half-life; present about 5 weeks after the last dose; steady state after 4 to 5 weekly doses).
- ZEPBOUND (tirzepatide) injection prescribing information
U.S. National Library of Medicine DailyMed / Eli Lilly · Last verified 2026-09-16
Used for Zepbound missed-dose, labeled weekly schedule, presentation-specific storage, and labeled injection pharmacokinetics (approximately 5-to-6-day half-life; steady state after 4 weekly doses).
- MOUNJARO (tirzepatide) injection prescribing information
U.S. National Library of Medicine DailyMed / Eli Lilly · Last verified 2026-09-16
Used for Mounjaro missed-dose, labeled weekly schedule, presentation-specific storage, and labeled injection pharmacokinetics (approximately 5-day half-life; steady state after 4 weekly doses).
Related WellForm MD resources
Need individualized guidance?
These tools are free public education. WellForm MD also provides physician-led medical weight-loss care when you want a plan that belongs to you.
Book a free consultation